本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

78.09
-0.9400-1.19%
盤後78.090.00000.00%19:30 EDT
成交量:71.10萬
成交額:5,555.06萬
市值:34.27億
市盈率:-72.14
高:79.10
開:78.67
低:77.33
收:79.03
52周最高:91.53
52周最低:53.85
股本:4,388.30萬
流通股本:3,563.83萬
量比:1.21
換手率:1.99%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
淨資產收益率:-13.68%
總資產收益率:-5.48%
市淨率:9.88
市盈率(LYR):-49.11

資料載入中...

2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/23

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/23

重要事件披露

Form 8-K - Current report
2026/02/18

重要事件披露

Form 8-K - Current report